
GENEREX
BIOTECHNOLOGY CORPORATION
33 Harbour
Square, Suite 202
Toronto,
Ontario, Canada M5J2G2
The purpose of this engagement letter is to
outline the agreement pursuant to which Maxim Group LLC (“
Maxim ”) will act as a non-exclusive placement agent
to Generex Biotechnology Corporation, I.R.S. Employer
Identification No. 98-0178636 (collectively, with its subsidiaries
and affiliates, the “ Company ”) in connection
with the proposed registered direct offering (the “
Offering ”) of warrants and shares of common stock,
par value $.001 per share (collectively, the “
Securities ”) of the Company. The terms of
such Offering and the Securities shall be mutually agreed upon by
the Company and the purchasers (each, a “
Purchaser ” and collectively, the “
Purchasers ”) and nothing herein constitutes
that Maxim would have the power or authority to bind the Company or
any Purchaser or an obligation for the Company to issue any
Securities or complete the Offering. This Agreement and the
documents executed and delivered by the Company and the Purchasers
in connection with the Offering shall be collectively referred to
herein as the “ Transaction
Documents .” The date of the closing of
the Offering shall be referred to herein as the “
Closing Date .” The Company
expressly acknowledges and agrees that Maxim’s obligations
hereunder are on a reasonable best efforts basis only and that the
execution of this Agreement does not constitute a commitment by
Maxim to purchase the Securities and does not ensure the successful
placement of the Securities or any portion thereof or the success
of Maxim with respect to securing any other financing on behalf of
the Company.
The terms of our agreement in principle are as
follows:
1. The
Company hereby engages Maxim, for the period beginning on the date
hereof and ending on September 15, 2009 , unless sooner
terminated pursuant to the terms of this engagement letter
agreement (the “ Engagement Period ”), to act as
the Company’s non-exclusive placement agent in connection
with the proposed Offering. Maxim agrees that, in
connection with the Offering, it will: (i) advise on pricing, and
other terms and conditions of the Offering, (ii) provide guidance
on general market conditions and their impact on the Offering, and
(iii) assist the Company in drafting and assisting in
the presentation that may be used to market the Offering
to existing and potential investors, describing the proposed
capital raising, the Company’s history and performance to
date, track records of key executives, highlights of the
Company’s business plan and the intended use of proceeds from
the Offering, and (iv) introduce the Company to potential investors
and broker-dealers representing potential investors, and assist
with the scheduling of presentations.
2. The
Offering shall consist of the issuance by the Company of up to
$14,350,000 worth of Securities. Maxim will act as a non-exclusive
placement agent of the Offering, subject to, among other things,
completion of Maxim’s due diligence examination of the
Company and its affiliates.
{00106182.DOC.2}Members FINRA &
SIPC
405 Lexington Ave. * New York, NY
10174 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 *
www.maximgrp.com
New York, NY * Long Island, NY * Red
Bank, NJ * Baltimore, MD
|
Page
2
|

|
3. The
Company agrees that it will not hold Maxim liable or responsible
for the failure of the Offering in the event that the Offering is
not consummated, either in whole or in part, for any
reason.
4. The
terms and conditions of the Offering shall be the subject of
continuing discussions between the Company and Maxim and will be
based on market and general economic conditions, the prospects
and/or forecasts of the Company and other factors.
The Company
represents and warrants to, and agrees with, Maxim that:
(A) The Company
filed with the Securities and Exchange Commission (the “
Commission ”) on December 22, 2006 a registration
statement on Form S-3 (Registration File No.333-139637) under the
Securities Act of 1933, as amended (the “ Securities
Act ”), as amended by Pre-Effective Amendment No. 1 on
January 1, 2007 which was declared effective on February 23, 20007
for the registration under the Securities Act of the Securities. At
the time of such filing, the Company met the requirements of Form
S-3 under the Securities Act. Such registration
statement meets the requirements set forth in Rule 415(a)(1)(x)
under the Securities Act and complies with said Rule. The Company
will file with the Commission pursuant to Rule 424(b) under the
Securities Act, and the rules and regulations (the “ Rules
and Regulations ”) of the Commission promulgated
thereunder, a supplement to the form of prospectus included in such
registration statement relating to the placement of the Securities
and the plan of distribution thereof and has advised the placement
agent of all further information (financial and other) with respect
to the Company required to be set forth therein. Such registration
statement, including the exhibits thereto, as amended at the date
of this agreement, is hereinafter called the “
Registration Statement ”; such prospectus in the form
in which it appears in the Registration Statement is hereinafter
called the “ Base Prospectus ”; and the
supplemented form of prospectus, in the form in which it will be
filed with the Commission pursuant to Rule 424(b) (including the
Base Prospectus as so supplemented) is hereinafter called the
“ Prospectus Supplement .” Any reference in this
agreement to the Registration Statement, the Base Prospectus or the
Prospectus Supplement shall be deemed to refer to and include the
documents incorporated by reference therein (the “
Incorporated Documents ”) pursuant to Item 12 of Form
S-3 which were filed under the Securities Exchange Act of 1934, as
amended (the “ Exchange Act ”), on or before the
date of this agreement, or the issue date of the Base Prospectus or
the Prospectus Supplement, as the case may be; and any reference in
this agreement to the terms “amend,”
“amendment” or “supplement” with respect to
the Registration Statement, the Base Prospectus or the Prospectus
Supplement shall be deemed to refer to and include the filing of
any document under the Exchange Act after the date of this
agreement, or the issue date of the Base Prospectus or the
Prospectus Supplement, as the case may be, deemed to be
incorporated therein by reference. All references in this agreement
to financial statements and schedules and other information which
is “contained,” “included,”
“described,” “referenced,” “set
forth” or “stated” in the Registration Statement,
the Base Prospectus or the Prospectus Supplement (and all other
references of like import) shall be deemed to mean and include all
such financial statements and schedules and other information which
is or is deemed to be incorporated by reference in the Registration
Statement, the Base Prospectus or the Prospectus Supplement, as the
case may be. No stop order suspending the effectiveness
of the Registration Statement or the use of the Base Prospectus or
the Prospectus Supplement has been issued, and no proceeding for
any such purpose is pending or has been initiated or, to the
Company's knowledge, is threatened by the Commission.
{00106182.DOC.2}Members FINRA &
SIPC
405 Lexington Ave. * New York, NY
10174 * tel (212) 895-3500 * (800) 724-0761 * fax (212) 895-3783 *
www.maximgrp.com
New York, NY * Long Island, NY * Red
Bank, NJ * Baltimore, MD
|
Page
3
|

|
(B) The
Registration Statement (and any further documents to be filed with
the Commission) contains all exhibits and schedules as required by
the Securities Act. Each of the Registration Statement and any
post-effective amendment thereto, at the time it became effective,
complied in all material respects with the Securities Act and the
Exchange Act and the applicable Rules and Regulations and did not
and, as amended or supplemented, if applicable, will not, contain
any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the
statements therein not misleading. The Base Prospectus and the
Prospectus Supplement, each as of its respective date, comply, or
will compy, as the case may be, in all material respects with the
Securities Act and the Exchange Act and the applicable Rules and
Regulations. Each of the Base Prospectus and the Prospectus
Supplement, as amended or supplemented, did not and will not
contain as of the date thereof any untrue statement of a material
fact or omit to state a material fact necessary in order to make
the statements therein, in light of the circumstances under which
they were made, not misleading. The Incorporated Documents, when
they were filed with the Commission, conformed in all material
respects to the requirements of the Exchange Act and the applicable
Rules and Regulations, and none of such documents, when they were
filed with the Commission, contained any untrue statement of a
material fact or omitted to state a material fact necessary to make
the statements therein (with respect to Incorporated Documents
incorporated by reference in the Base Prospectus or Prospectus
Supplement), in light of the circumstances under which they were
made not misleading; and any further documents so filed and
incorporated by reference in the Base Prospectus or Prospectus
Supplement, when such documents are filed with the Commission, will
conform in all material respects to the requirements of the
Exchange Act and the applicable Rules and Regulations, as
applicable, and will not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they
were made, not misleading. No post-effective amendment to the
Registration Statement reflecting any facts or events arising after
the date thereof which represent, individually or in the aggregate,
a fundamental change in the information set forth therein is
required to be filed with the Commission. There are no
documents required to be filed with the Commission in connection
with the transaction contemplated hereby that (x) have not been
filed as required pursuant to the Securities Act or (y) will not be
filed within the requisite time period. There are no contracts or
other documents required to be described in the Base Prospectus or
Prospectus Supplement, or to be filed as exhibits or schedules to
the Registration Statement, which have not been described or filed
as required.
(C)
[intentionally deleted]
(D) The
Company has delivered, or will as promptly as practicable deliver,
to Maxim copies of the Base Prospectus and the Prospectus
Supplement, as amended or supplemented, in such quantities and at
such places as Maxim reasonably requests. Neither the
Company nor any of its directors and officers has distributed and
none of them will distribute, prior to the Closing Da

|